Fe3O4-viral-like Mesoporous Silica Nanoparticle(Fe3O4-vMSN)-Sustained Release of Lenvatinib for Targeted Treatment of Hepatocellular Carcinoma.
Sign Up to like & getrecommendations! Published in 2025 at "Current cancer drug targets"
DOI: 10.2174/0115680096329105241031093859
Abstract: BACKGROUND Lenvatinib is an oral tyrosine kinase inhibitor that selectively inhib-its receptors involved in tumor angiogenesis and tumor growth. It is an emerging first-line treatment agent for hepatocellular carcinoma (HCC). However, there is no intravenous… read more here.
Keywords: viral like; fe3o4 vmsn; hepatocellular carcinoma; vmsn ... See more keywords